Stock Ticker

  • Loading stock data...

Mylan NV (NASDAQ:MYL) Rejects Teva-Takeover, Calls The Bid Undervalued

Global pharmaceutical company Mylan NV (NASDAQ:MYL) chose to reject the unsolicited buyout bid by Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). The decision was made unanimously by the current Board of Directors. Teva Undervalued Mylan The opinionated directors believe that the bid approached by Teva authorities was lackluster, in all regards. The price quoted for Mylan […]